Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Think of this as a partnership
How it works Most people run more than one compound
Just because its non-preferred doesnt mean itll never be covered
It is in development for both type 2 diabetes and weight management
Lacosamide (LCM), a novel drug with the reduction of HDAC1 protein expression in preclinical studies as mentioned above, was licensed in 2008 by FDA/EMA as an adjunctive treatment for curing partial-onset seizures in adolescent patients attacked by epilepsy
US$ 28.51
US$ 26.00
US$ 25.19
US$ 24.16
US$ 27.07
